The 20 Best Jalili Syndrome Doctors Near Me

Khanti Rattanapornsompong practices practicing medicine in Bangkok, Thailand. Rattanapornsompong is rated as an Elite expert by MediFind in the treatment of Jalili Syndrome. They are also highly rated in 6 other conditions, according to our data. Their clinical expertise encompasses Cone Rod Dystrophy Amelogenesis Imperfecta, Jalili Syndrome, Cone-Rod Dystrophy, and Maffucci Syndrome.

Robert Sisk is an Ophthalmologist practicing medicine in Blue Ash, Ohio. He has been practicing medicine for over 23 years. Dr. Sisk is rated as a Distinguished provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 59 other conditions, according to our data. His clinical expertise encompasses Cone Dystrophy, Retinal Detachment, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Sisk is board certified in American Board Of Ophthalmology - 2008. Dr. Sisk is currently accepting new patients.

We provide exceptional care and compassionate service to optimize the vision of patients with retinal disease. Dr. Telander is rated as a Distinguished provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Leber Congenital Amaurosis, Sorsby Fundus Dystrophy, and Vitrectomy. Dr. Telander is board certified in Ophthalmology. Dr. Telander is currently accepting new patients.

Mandeep S. Singh, M.D., Ph.D., is associate professor of ophthalmology and genetic medicine in the Retina Division of the Wilmer Eye Institute and the recipient of the 2023 Andreas C. Dracopoulos Professorship in Ophthalmology. Dr. Singh is a retinal specialist. He is Co-Director of the Genetic Eye Disease (GEDi) Center, and is a principal investigator at the Center for Stem Cells and Ocular Regenerative Medicine (STORM). Dr. Singh completed his medical degree at the National University of Singapore. In 2009, he was elected to the Fellow of the Royal College of Surgeons of Edinburgh. He earned a PhD in ophthalmology from the University of Oxford, United Kingdom, in 2014. He completed fellowships in vitreoretinal diseases and surgery at the Oxford Eye Hospital and Moorfields Eye Hospital, both in the United Kingdom. His clinical expertise includes surgical, medical and genetic conditions of the retina and macula. Dr. Singh is specialty-trained in vitrectomy surgery for retinal detachment, macular holes, macular pucker, epiretinal membrane, proliferative vitreoretinopathy, complex retinal detachments including reoperations, vitreous hemorrhage removal, and other retinal surgeries. He also specializes in age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion, and choroidal neovascularization. Dr. Singh sees patients and families with genetic retinal diseases such as retinitis pigmentosa, Usher syndrome, Stargardt disease and macular dystrophies. His research focus is retinal stem cell transplantation. Dr. Singh’s work has been recognized through the Eye Institute–Allergan Research Prize, the Merton College University of Oxford Graduate Prize Scholarship, the Oxford Ophthalmological Congress Founder’s Cup and Medal, the Ruskell Medal, the Johns Hopkins Clinician Scientist Award, and the Bert M. Glaser, MD Award for Innovative Research in Retina. He is a member of the American Academy of Ophthalmology and the Association for Research in Vision and Ophthalmology. He is also a member of the Club Jules Gonin and the Macula Society. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Singh_CV.pdf. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Retinitis Pigmentosa, Stargardt Macular Degeneration, Late-Onset Retinal Degeneration, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

Dr. Louwagie is an ophthalmologist at Avera Marshall Southwest Ophthalmology. Dr. Louwagie is rated as an Advanced provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Cataract, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Retinal Vein Occlusion. Dr. Louwagie is board certified in American Board Of Ophthalmology.

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Advanced provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Howard Cummings is an Ophthalmologist practicing medicine in Knoxville, Tennessee. Dr. Cummings is rated as an Experienced provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Retinal Detachment. Dr. Cummings is board certified in American Board Of Ophthalmology.

Mark Kleinman is an Ophthalmologist practicing medicine in Kingsport, Tennessee. Dr. Kleinman is rated as an Experienced provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Central Serous Chorioretinopathy. Dr. Kleinman is board certified in American Board Of Ophthalmology.

Michael Magee is an Ophthalmologist practicing medicine in Kingsport, Tennessee. Dr. Magee is rated as an Experienced provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Late-Onset Retinal Degeneration, and Retinal Vein Occlusion. Dr. Magee is board certified in American Board Of Ophthalmology.

Tomas Aleman is an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Aleman is rated as a Distinguished provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Choroideremia, Leber Congenital Amaurosis, Retinopathy Pigmentary Mental Retardation, and Cone-Rod Dystrophy. Dr. Aleman is board certified in Ophthalmology, 2019. Dr. Aleman is currently accepting new patients.

Philip Rosenfeld is an Ophthalmologist practicing medicine in Miami, Florida. Dr. Rosenfeld is rated as an Experienced provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Carotid Artery Surgery, and Vitrectomy. Dr. Rosenfeld is currently accepting new patients.

Thomas Hejkal is an Ophthalmologist practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 36 years. Dr. Hejkal is rated as an Experienced provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Choroid Plexus Carcinoma, and Retinal Artery Occlusion.

Anastasia Traband is an Ophthalmologist practicing medicine in Wyomissing, Pennsylvania. Dr. Traband is rated as an Experienced provider by MediFind in the treatment of Jalili Syndrome. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Retinal Artery Occlusion, and Vitrectomy. Dr. Traband is board certified in American Board Of Ophthalmology.

Angela Barbera is an Ophthalmologist practicing medicine in Wyomissing, Pennsylvania. Dr. Barbera is rated as an Experienced provider by MediFind in the treatment of Jalili Syndrome. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Retinal Detachment. Dr. Barbera is board certified in American Board Of Ophthalmology.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Experienced provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Cone Dystrophy, and Usher Syndrome Type 2A.

Tapan Patel is an Ophthalmologist practicing medicine in Wyomissing, Pennsylvania. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Vitrectomy, and Cataract Removal. Dr. Patel is board certified in American Board Of Ophthalmology.

Kimberly Stepien, MD, is a UW Health ophthalmologist (eye specialist) with expertise in retinal diseases and disorders. She's also a professor in the Department of Ophthalmology and Visual Sciences at the University of Wisconsin School of Medicine and Public Health.Dr. Stepien diagnoses and treats inherited retinal disease, age-related macular degeneration, diabetic retinopathy, blocked retinal blood vessels (retinal vascular occlusions) and other eye conditions. She directs a subspecialty clinic for patients with inherited retinal disease. These include retinitis pigmentosa (RP) and rare genetic disorders, such as Stargardt disease.Taking a personalized approach to care, Dr. Stepien treats patients with respect and compassion. She helps them understand their condition and treatment options, focusing on unique needs and preferences. Dr. Stepien empowers patients and their families to make health care decisions that work best for them.In addition to patient care, Dr. Stepien researches inherited retinal diseases and advanced imaging. She leads clinical trials to better understand and treat retinal diseases. Dr. Stepien co-directs the Wisconsin Advanced Imaging of the Visual System (WAIVS) lab. Her team explores innovative high-resolution imaging of the eyes.In her free time, Dr. Stepien enjoys spending time with her family, running, hiking, gardening and other outdoor activities.Eyesight impacts almost every aspect of our lives. To help a person see or to keep a person seeing significantly improves their quality of life and is very rewarding. Dr. Stepien is rated as a Distinguished provider by MediFind in the treatment of Jalili Syndrome. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Usher Syndrome, Stargardt Macular Degeneration, Choroideremia, and Jalili Syndrome. Dr. Stepien is board certified in Ophthalmology.

Abigail Fahim is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 17 years. Dr. Fahim is rated as a Distinguished provider by MediFind in the treatment of Jalili Syndrome. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, and Usher Syndrome Type 2A. Dr. Fahim is board certified in Ophthalmology.

"Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models of Pde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies.He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: “Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics"" and “Stem Cell Biology and Regenerative Medicine in Ophthalmology”, Springer Press, NY; and “CRISPR Genome Surgery in Stem Cells and Disease Tissues”, Elsevier Inc. He is an elected member of several honorary societies including the American Society for Clinical Investigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel - Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such as Science, NEJM, Lancet, Cell Stem Cell, Nature Genetics, and Journal of Clinical Investigation, which attests to the broad impact that his work has had.Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.". Dr. Tsang is rated as a Distinguished provider by MediFind in the treatment of Jalili Syndrome. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Leber Congenital Amaurosis, Sorsby Fundus Dystrophy, Usher Syndrome, and Cone Rod Dystrophy Amelogenesis Imperfecta. Dr. Tsang is board certified in Ophthalmology. Dr. Tsang is currently accepting new patients.

Jiong Yan is an Ophthalmologist practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 28 years. Dr. Yan is rated as an Advanced provider by MediFind in the treatment of Jalili Syndrome. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, X-Linked Retinitis Pigmentosa (XLRP), Vitrectomy, and Myringotomy. Dr. Yan is board certified in American Board Of Ophthalmology, 2004.